BioAlliance Pharma Receives Approval to Begin ReLive Phase III Clinical Trial in Primary Liver Cancer in the US and Germany
December 04, 2013 at 13:44 PM EST
BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology and to… Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an